Denopamine is a potent orally-active cardiotonic with selective effects on the beta,
adrenergic receptors. Unlike isoproterenol or dobutamine, denopamine’s positive
inotropic activity is not mediated through the release of catecholamines; its lack of effect
on heart rate and myocardial oxygen consumption thus offers significant advantages in the
management of congestive heart failure.